Literature DB >> 12502681

A cross-sectional study of the effects of type 2 diabetes and other cardiovascular risk factors on structure and function of nonstenotic arteries of the lower limb.

David N O'Neal1, George Dragicevic, Kevin G Rowley, Mohamed Z Ansari, Nicholas Balazs, Alicia Jenkins, James D Best.   

Abstract

OBJECTIVE: To compare intimal-medial thickness (IMT) and pulse wave conduction velocity (PWCV) in unstenosed arteries of the lower limb in subjects with and without type 2 diabetes and to determine the contribution of a range of cardiovascular risk factors. RESEARCH DESIGN AND METHODS: IMT and PWCV were determined in lower-limb arteries of 79 subjects with diabetes and 77 euglycemic subjects. Plasma lipids were determined by enzymatic assays, and LDL particle size was measured by gradient gel electrophoresis. Lag time for copper-induced oxidation of LDL was determined. alpha-Tocopherol, retinol, and ascorbate levels were determined by high-performance liquid chromatography, soluble E-selectin by enzyme-linked immunosorbent assay, and fibrinogen and factor VII by automated assays.
RESULTS: Subjects with diabetes had greater superficial femoral artery (SFA) IMT, popliteal artery (PA) IMT, and SFA PWCV (all P < 0.0001). In univariate analysis, IMT and PWCV correlated with increased waist-to-hip ratio, triglycerides, and fibrinogen and inversely with HDL cholesterol and LDL size. Ascorbate was inversely associated with IMT, and LDL lag time was inversely correlated with PWCV. Subjects with the greatest number of features of the metabolic syndrome had the highest IMT and PWCV.
CONCLUSIONS: Adverse changes in the structure and function of unstenosed lower-limb arteries are present in type 2 diabetes and are associated with features of the metabolic syndrome.

Entities:  

Mesh:

Year:  2003        PMID: 12502681     DOI: 10.2337/diacare.26.1.199

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  11 in total

Review 1.  Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease.

Authors:  C D A Stehouwer; R M A Henry; I Ferreira
Journal:  Diabetologia       Date:  2008-02-01       Impact factor: 10.122

2.  Estrogen receptor-α but not -β or GPER inhibits high glucose-induced human VSMC proliferation: potential role of ROS and ERK.

Authors:  Jana Ortmann; Martha Veit; Sandra Zingg; Stefano Di Santo; Tobias Traupe; Zijiang Yang; Jan Völzmann; Raghvendra K Dubey; Stephan Christen; Iris Baumgartner
Journal:  J Clin Endocrinol Metab       Date:  2010-10-20       Impact factor: 5.958

Review 3.  The role of exercise in the treatment of cardiovascular disease associated with type 2 diabetes mellitus.

Authors:  Jonathan M McGavock; Neil D Eves; Sandra Mandic; Nicole M Glenn; H Arthur Quinney; Mark J Haykowsky
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

4.  Vascular function measured by fingertip thermal reactivity is impaired in patients with metabolic syndrome and diabetes mellitus.

Authors:  Naser Ahmadi; Fereshteh Hajsadeghi; Khawar Gul; Michael Leibfried; Daniel DeMoss; Robert Lee; Ferdinand Flores; Khurram Nasir; Harvey Hecht; Morteza Naghavi; Matthew J Budoff
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-11       Impact factor: 3.738

5.  Relationships between Brachial-Ankle Pulse Wave Velocity and Peripheral Neuropathy in Type 2 Diabetes.

Authors:  Byung Kil Ha; Bong Gun Kim; Dong Hyun Kim; Soon Il Lee; Soon Myung Jung; Ja Young Park; Chang Won Lee; Sang Soo Kim; Bo Hyun Kim; In Ju Kim
Journal:  Diabetes Metab J       Date:  2012-12-12       Impact factor: 5.376

6.  Impact of the metabolic syndrome and its components on pulse wave velocity.

Authors:  Young-Kwon Kim
Journal:  Korean J Intern Med       Date:  2006-06       Impact factor: 2.884

7.  Transcranial Doppler ultrasound assessment of intracranial hemodynamics in patients with type 2 diabetes mellitus.

Authors:  Marinko Dikanovic; Izet Hozo; Slaven Kokic; Marina Titlic; Marica Jandric; Ivan Balen; Dragutin Kadojic
Journal:  Ann Saudi Med       Date:  2005 Nov-Dec       Impact factor: 1.526

8.  Peripheral Arterial Disease in Type 2 Diabetes Is Associated with an Increase in Fibrinogen Levels.

Authors:  Qin-Fen Chen; Dan Cao; Ting-Ting Ye; Hui-Hui Deng; Hong Zhu
Journal:  Int J Endocrinol       Date:  2018-11-08       Impact factor: 3.257

9.  Influence of fibrinogen and C-RP on progression of peripheral arterial disease in type 2 diabetes: a preliminary report.

Authors:  Marijan Bosevski; Golubinka Bosevska; Lily Stojanovska
Journal:  Cardiovasc Diabetol       Date:  2013-02-01       Impact factor: 9.951

10.  Independent association between glycated hemoglobin and arterial stiffness in healthy men.

Authors:  Jin-Won Noh; Eun-Jung Kim; Hyun-Ju Seo; Soo Geun Kim
Journal:  J Diabetes Investig       Date:  2015-07-30       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.